GGrantIndex
← Leaderboards

Andrew J Dannenberg

Weill Medical College Of Cornell Univ

Google Scholar ↗PubMed ↗ORCID ↗
$7,046,240
Attributed
$8,172,192
Total exposure
11
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY2005–20
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$8,172,192 · 11

By mechanism

R01$6,269,376 · 5
P01$1,638,622 · 1
R21$199,734 · 1
M01$64,460 · 4

Top collaborators

Most similar at Weill Medical College Of Cornell Univ

Same institution · by research overlap

Others in their field

Top investigators on “Prostaglandin Endoperoxide Synthase”

Research focus

Prostaglandin Endoperoxide SynthaseEnzyme Induction /RepressionChemopreventionWomanNeoplasm /Cancer ChemotherapyTissuesReportingMetastasisBaseNonhuman Therapy EvaluationEstrogensMalignant Breast NeoplasmDinoprostoneEnzymesObesityCyclooxygenase 2PostmenopauseMediatingMammary GlandAromataseBreastInflammationCelecoxibIncidence

Grant awards (27)

Breast White Adipose Tissue Inflammation and Breast Cancer Outcomes$981,204
R01 · FY2020 · CA
Reducing breast cancer risk through modifying body composition and decreasing inflammation in normal weight women$199,734
R21 · FY2020 · CA
Obesity Increases Breast Cancer Penetrance in BRCA Mutation Carriers: A Role for Local and Systemic Factors$555,691
R01 · FY2018 · CA · contact PI
Obesity Increases Breast Cancer Penetrance in BRCA Mutation Carriers: A Role for Local and Systemic Factors$515,275
R01 · FY2017 · CA · contact PI
Targeting the Obesity-Inflammation-COX-Aromatase Axis to Lower Breast Cancer Risk$350,675
R01 · FY2015 · CA · contact PI
Targeting the Obesity-Inflammation-COX-Aromatase Axis to Lower Breast Cancer Risk$340,155
R01 · FY2014 · CA · contact PI
Targeting the Obesity-Inflammation-COX-Aromatase Axis to Lower Breast Cancer Risk$329,635
R01 · FY2013 · CA · contact PI
Targeting the Obesity-Inflammation-COX-Aromatase Axis to Lower Breast Cancer Risk$350,675
R01 · FY2012 · CA · contact PI
Targeting the Obesity-Inflammation-COX-Aromatase Axis to Lower Breast Cancer Risk$350,675
R01 · FY2011 · CA · contact PI
COX-2: A Target for the Prevention of Cervical Cancer$464,357
P01 · FY2008 · CA · contact PI
COX-2: A Target for the Prevention of Cervical Cancer$459,280
P01 · FY2007 · CA · contact PI
URINARY PGE-M, BIOMARKER OF TOBACCO-SMOKE LUNG INJURY$6,764
M01 · FY2007 · RR · contact PI
EFFECTS OF CIGARETTE SMOKE ON CYCLOXYGENASE-2 IN ORAL MUCOSA$4,220
M01 · FY2007 · RR · contact PI
COX-2: A Target for the Prevention of Cervical Cancer$243,344
P01 · FY2006 · CA · contact PI
URINARY PGE-M, BIOMARKER OF TOBACCO-SMOKE LUNG INJURY$36,461
M01 · FY2006 · RR · contact PI
EFFECTS OF CIGARETTE SMOKE ON CYCLOXYGENASE-2 IN ORAL MUCOSA$17,015
M01 · FY2006 · RR · contact PI
CYCLOOXYGENASE 2 ABD PREVENTION OF HEAD AND NECK CANCER$274,710
R01 · FY2005 · CA
COX-2: A Target for the Prevention of Cervical Cancer$234,758
P01 · FY2005 · CA
CYCLOOXYGENASE 2 ABD PREVENTION OF HEAD AND NECK CANCER$274,710
R01 · FY2004 · CA
NEW THARAPY FOR HER 2/NEU POSITIVE BREAST CANCER$271,773
R01 · FY2004 · CA
COX-2: A Target for the Prevention of Cervical Cancer$236,883
P01 · FY2004 · CA
CYCLOOXYGENASE 2 ABD PREVENTION OF HEAD AND NECK CANCER$274,710
R01 · FY2003 · CA
NEW THARAPY FOR HER 2/NEU POSITIVE BREAST CANCER$271,773
R01 · FY2003 · CA
CYCLOOXYGENASE 2 ABD PREVENTION OF HEAD AND NECK CANCER$280,339
R01 · FY2002 · CA
NEW THARAPY FOR HER 2/NEU POSITIVE BREAST CANCER$274,466
R01 · FY2002 · CA
NEW THARAPY FOR HER 2/NEU POSITIVE BREAST CANCER$286,455
R01 · FY2001 · CA
CYCLOOXYGENASE 2 ABD PREVENTION OF HEAD AND NECK CANCER$286,455
R01 · FY2001 · CA